Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in lenalidomide (len)-refractory patients (pts) with progressive ...
PCT1:CO-STIM TCR T-cells to overcome the hostile tumor micro-environment and target triple-negative breast cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results